[1]
|
Ostrom, Q.T., Bauchet, L., Davis, F.G., et al. (2014) The Epidemiology of Glioma in Adults: A “State of the Science” Review. Neuro-Oncology, 16, 896-913. https://doi.org/10.1093/neuonc/nou087
|
[2]
|
Louis, D.N., Perry, A., Reifenberger, G., et al. (2016) The 2016 World Health Organization Classification of Tumors of the Central Nervous System: A Summary. Acta Neuropathologica, 131, 803-820. https://doi.org/10.1007/s00401-016-1545-1
|
[3]
|
Louis, D.N., Perry, A., Wesseling, P., et al. (2021) The 2021 WHO Classification of Tumors of the Central Nervous System: A Summary. Neuro-Oncology, 23, 1231-1251. https://doi.org/10.1093/neuonc/noab106
|
[4]
|
Yan, H., Parsons, D.W., Jin, G., et al. (2009) IDH1 and IDH2 Mutations in Gliomas. The New England Journal of Medicine, 360, 765-773. https://doi.org/10.1056/NEJMoa0808710
|
[5]
|
Weller, M., Van Den Bent, M., Preusser, M., et al. (2021) EANO Guidelines on the Diagnosis and Treatment of Diffuse Gliomas of Adulthood. Nature Reviews Clinical Oncology, 18, 170-186. https://doi.org/10.1038/s41571-020-00447-z
|
[6]
|
Choi, Y., Nam, Y., Lee, Y.S., et al. (2020) IDH1 Mutation Prediction Using MR-Based Radiomics in Glioblastoma: Comparison between Manual and Fully Automated Deep Learning-Based Approach of Tumor Segmentation. European Journal of Radiology, 128, Article ID: 109031. https://doi.org/10.1016/j.ejrad.2020.109031
|
[7]
|
Tan, Y., Zhang, S.T., Wei, J.W., et al. (2019) A Radiomics Nomogram May Improve the Prediction of IDH Genotype for Astrocytoma before Surgery. Eurpean Radiology, 29, 3325-3337. https://doi.org/10.1007/s00330-019-06056-4
|
[8]
|
Wang, J., Hu, Y., Zhou, X., et al. (2022) A Radiomics Model Based on DCE-MRI and DWI May Improve the Prediction of Estimating IDH1 Mutation and Angiogenesis in Gliomas. European Journal of Radiology, 147, Article ID: 110141. https://doi.org/10.1016/j.ejrad.2021.110141
|
[9]
|
Wang, N., Xie, S.Y., Liu, H.M., et al. (2019) Arterial Spin Labeling for Glioma Grade Discrimination: Correlations with IDH1 Genotype and 1p/19q Status. Translational Oncology, 12, 749-756. https://doi.org/10.1016/j.tranon.2019.02.013
|
[10]
|
Patel, S.H., Poisson, L.M., Brat, D.J., et al. (2017) T2-FLAIR Mismatch, an Imaging Biomarker for IDH and 1p/19q Status in Lower-Grade Gliomas: A TCGA/TCIA Project. Clinical Cancer Research, 23, 6078-6085. https://doi.org/10.1158/1078-0432.CCR-17-0560
|
[11]
|
林坤, 王晓明. Nomogram在脑胶质瘤MR术前病理分级中的应用[J]. 中国医学影像学杂志, 2023, 31(5): 442-447.
|
[12]
|
Hartmann, M., Jansen, O., Egelhof, T., et al. (1998) Effect of Brain Edema on the Recurrence Pattern of Malignant Gliomas. Der Radiologe, 38, 948-953. https://doi.org/10.1007/s001170050447
|
[13]
|
周小焙. 磁共振影像组学、常规特征与DWI量化特征对脑胶质瘤分级诊断的初步研究[D]: [硕士学位论文]. 衡阳: 南华大学衡阳医学院, 2021.
|
[14]
|
Berzero, G., Di Stefano, A.L., Ronchi, S., et al. (2021) IDH-Wildtype Lower-Grade Diffuse Gliomas: The Importance of Histological Grade and Molecular Assessment for Prognostic Stratification. Neuro-Oncology, 23, 955-966. https://doi.org/10.1093/neuonc/noaa258
|
[15]
|
Do, Y.A., Cho, S.J., Choi, B.S., et al. (2022) Predictive Accuracy of T2-FLAIR Mismatch Sign for the IDH-Mutant, 1p/19q Noncodeleted Low-Grade Glioma: An Updated Systematic Review and Meta-Analysis. Neuro-Oncology Advances, 4, vdac010. https://doi.org/10.1093/noajnl/vdac010
|
[16]
|
Adamou, A., Beltsios, E.T. and Papanagiotou, P. (2021) The T2-FLAIR Mismatch Sign as an Imaging Indicator of IDH-Mutant, 1p/19q Non-Codeleted Lower Grade Gliomas: A Systematic Review and Diagnostic Accuracy Meta-Analysis. Diagnostics (Basel, Switzerland), 11, Article No. 1620. https://doi.org/10.3390/diagnostics11091620
|
[17]
|
郗艳, 曹胜男, 舒政. T2-T2 FLAIR错配征预测胶质瘤IDH1突变状态的价值[J]. 临床放射学杂志, 2023, 42(3): 391-395.
|
[18]
|
Deguchi, S., Oishi, T., Mitsuya, K., et al. (2020) Clinicopathological Analysis of T2-FLAIR Mismatch Sign in Lower-Grade Gliomas. Scientific Reports, 10, Article No. 10113. https://doi.org/10.1038/s41598-020-67244-7
|
[19]
|
Kickingereder, P., Sahm, F., Radbruch, A., et al. (2015) IDH Mutation Status Is Associated with a Distinct Hypoxia/Angiogenesis Transcriptome Signature Which Is Non-Invasively Predictable with rCBV Imaging in Human Glioma. Scientific Reports, 5, Article No. 16238. https://doi.org/10.1038/srep16238
|
[20]
|
Qi, S., Yu, L., Li, H., et al. (2014) Isocitrate Dehydrogenase Mutation Is Associated with Tumor Location and Magnetic Resonance Imaging Characteristics in Astrocytic Neoplasms. Oncology Letters, 7, 1895-1902. https://doi.org/10.3892/ol.2014.2013
|
[21]
|
Nishiyama, Y., Sasaki, H., Nagahisa, S., et al. (2014) Radiological Features of Supratentorial Gliomas Are Associated with Their Genetic Aberrations. Neurosurgical Review, 37, 291-299. https://doi.org/10.1007/s10143-013-0515-5
|
[22]
|
Cao, M., Suo, S., Zhang, X., et al. (2021) Qualitative and Quantitative MRI Analysis in IDH1 Genotype Prediction of Lower-Grade Gliomas: A Machine Learning Approach. BioMed Research International, 2021, Article ID: 1235314. https://doi.org/10.1155/2021/1235314
|
[23]
|
夏晓亮, 夏云宝, 陈利华, 等. 基于MRI特征的脑胶质瘤异柠檬酸脱氢酶1表达预测研究[J]. 东南国防医药, 2020, 22(3): 262-267.
|
[24]
|
Balss, J., Meyer, J., Mueller, W., et al. (2008) Analysis of the IDH1 Codon 132 Mutation in Brain Tumors. Acta Neuropathologica, 116, 597-602. https://doi.org/10.1007/s00401-008-0455-2
|